Pharmaceuticals, Biotechnology and Life Sciences
Non-dilutive capital will support advancement of ADXS-HOT neoantigen programPRINCETON, N.J., April 26, 2021 (GLOBE NEWSWIRE) — Advaxis, Inc. (NASDAQ: ADXS), a…
LONDON and DUBLIN, April 23, 2021 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH) (GW) and Jazz Pharmaceuticals plc (Nasdaq:…
SUZHOU and SHANGHAI, China, April 23, 2021 (GLOBE NEWSWIRE) — Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical…
MALVERN, Pa., April 23, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (Nasdaq: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing…
Lille, France; Cambridge, MA; April 23, 2021 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving…
PD-1 Antagonist Antibody Under Clinical Development for Solid Tumors in Collaboration with GlaxoSmithKline (GSK)First AnaptysBio-Generated Antibody, of 8 Currently Under…
Pratteln, Switzerland, April 23, 2021 – Santhera Pharmaceuticals (SIX: SANN) will announce its audited 2020 results on Thursday, April 29, 2021, at…
New Dupixent® (dupilumab) analyses reinforce long-term safety and efficacy profile in patients with atopic dermatitis as young…
Daily treatment with sofpironium bromide gel was generally well-tolerated over 48 weeks of treatment Efficacy assessments showed a clinically meaningful…
Detailed results from Phase 2b study of roflumilast foam in scalp and body psoriasis featured in late-breaking oral presentationData demonstrate…